Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tesaro’s niraparib secures FDA priority review for late stage ovarian cancer
Image: FDA grants priority review to Tesaro’s niraparib for late stage ovarian cancer. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.
Image: FDA grants priority review to Tesaro’s niraparib for late stage ovarian cancer. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.